Mercury vs Neuralink
Side-by-side equity comparison for employees weighing offers at Mercury or Neuralink. Valuations, funding history, headcount growth, and secondary-market context.
| Mercury | Neuralink | |
|---|---|---|
| Latest valuation | $4B | $10B |
| Latest round | Series C | Series D |
| Round date | June 2024 | November 2024 |
| Total raised | $213M | $680M |
| Founded | 2017 | 2016 |
| Headquarters | San Francisco, CA | Fremont, CA |
| Employees | 2,814 | 628 |
| Employee YoY growth | -2% | +19% |
| Primary industry | Fintech | Healthcare & Biotech |
| Secondary-market price | $12.24 | — |
| Base-case equity multiple | 1x | 1x |
| Upside equity multiple | 1x | 1x |
| Lead investors | Sequoia Capital, Andreessen Horowitz | Founders Fund, GV (Google Ventures) |
| Status | private | private |
Overview
Mercury is a financial technology company that provides banking services tailored for startups, including checking and savings accounts, treasury management, and corporate cards.
Neuralink develops implantable brain-computer interfaces designed to enable people with paralysis to control digital devices with their thoughts.
Why we compare these
Mercury and Neuralink both appear on Sara's List 2024 .
If you're evaluating offers at either one, the equity math depends on more than the headline valuation — dilution, strike price, time to liquidity, and concentration risk all matter. Use our equity compensation calculator and exit calculator to model your own numbers.